WolverHeme Happy Hour cover image

Episode 32: Navigating a BlinatumoMAD World

WolverHeme Happy Hour

00:00

Where Blinatumomab Fits Across Age Groups and Risk Levels

Hosts and guests summarize current practice: broad blinatumomab use in B‑cell ALL MRD settings and gaps for AYA/high‑risk populations.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app